Related Experiment Video
Updated: May 4, 2026

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection
Published on: June 8, 2020
DNA testing and molecular screening for colon cancer
1Division of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.
DNA testing is crucial for colon cancer care, identifying hereditary risks and guiding treatment. Advances in molecular screening and genetic sequencing promise more accurate detection and personalized medicine approaches for better patient outcomes.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Colon cancer arises from abnormal cellular molecular changes, often involving mutant DNA.
- Modern molecular techniques enable analysis of patient genetic data for risk assessment, outcome prediction, and therapy modification.
- DNA testing and molecular screening are integral to current patient care and are becoming increasingly essential.
Purpose of the Study:
- To highlight the evolving role of DNA testing and molecular screening in colon cancer diagnosis and management.
- To discuss the shift towards comprehensive genomic sequencing for hereditary colon cancer assessment.
- To emphasize the importance of molecular profiling for guiding targeted therapies and predicting treatment responses.
Main Methods:
- Examination of individual patient genetic data.
- Analysis of mutant DNA from shed tumor cells in fecal material for screening.
- Detection of DNA mutations and molecular changes directly from colon cancer tissue.
- Assessment of mutation status for specific genes (e.g., KRAS, BRAF, PIK3CA) to guide therapy.
Main Results:
- DNA testing provides critical information for risk stratification and therapeutic decisions in colon cancer.
- Future approaches will likely involve whole exome or whole genome sequencing for a broader understanding of patient genomes.
- Fecal DNA testing for screening is expected to improve in accuracy with advancements in technology and methodology.
- Molecular profiling informs the use of targeted therapies, such as epidermal growth factor receptor inhibitors, and predicts response to adjuvant treatments like aspirin.
Conclusions:
- Precision medicine, driven by molecular insights, is increasingly adopted for optimal colon cancer patient care and outcomes.
- Gastroenterologists require enhanced awareness of these molecular advancements to effectively manage patients.
- Integrating genetic and molecular data is essential for personalized colon cancer treatment strategies.
More Related Videos
05:58Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
Published on: August 20, 2018
06:21Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
Related Concept Videos
Serum Laboratory Studies, Stool Test, Breath Test
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...